Compagnie Lombard Odier SCmA - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$5,000
-37.5%
1,1000.0%0.00%
Q3 2021$8,000
-20.0%
1,1000.0%0.00%
Q2 2021$10,0000.0%1,1000.0%0.00%
Q1 2021$10,0001,1000.00%
Q2 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2017$16,000
+23.1%
2,0000.0%0.00%
Q1 2017$13,000
-7.1%
2,0000.0%0.00%
Q4 2016$14,000
-26.3%
2,0000.0%0.00%
-100.0%
Q3 2016$19,000
+5.6%
2,0000.0%0.00%0.0%
Q2 2016$18,000
-52.6%
2,000
-54.5%
0.00%0.0%
Q1 2016$38,000
+100.0%
4,400
+51.7%
0.00%0.0%
Q4 2015$19,0002,9000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Round Table Services, LLC 129,500$1,207,0000.72%
STONERIDGE INVESTMENT PARTNERS LLC 252,376$2,352,0000.34%
Bellevue Group AG 155,000$1,445,0000.26%
WASATCH ADVISORS LP 1,861,553$17,350,0000.26%
Blue Clay Capital Management, LLC 13,000$121,0000.14%
Virtus ETF Advisers LLC 24,058$224,0000.11%
EMERALD ADVISERS, LLC 203,737$1,899,0000.08%
Vident Investment Advisory, LLC 63,383$591,0000.08%
Thomas J. Herzfeld Advisors, Inc. 15,000$140,0000.08%
GSA CAPITAL PARTNERS LLP 94,400$880,0000.05%
View complete list of INOVIO PHARMACEUTICALS INC shareholders